Reginald V N Lord is an upper gastrointestinal and general surgeon at St. Vincent’s Hospital, St. Vincent’s Private Hospital, and Macquarie University Hospital, Sydney. His clinical interests include diseases of the oesophagus and stomach, including gastro-oesophageal reflux disease (GORD) and hiatus hernia, Barrett’s oesophagus, oesophageal cancer and gastric (stomach) cancer, surgery for weight loss and weight-related metabolic diseases such as diabetes, and surgery for gallstones and hernia.
Professor Lord received his undergraduate degree (M.B.B.S.) from Sydney University, a postgraduate research degree (M.D.) from the University of New South Wales, and is a Fellow of the Royal Australasian College of Surgeons. He trained in surgery at St. Vincent’s Hospital, Sydney, and at the University of Southern California, Los Angeles, where he worked for more than five years as a fellow and Assistant Professor. During his time at the University of Southern California he was a member of the team that first described the sleeve gastrectomy operation for weight loss and he is one of the first surgeons worldwide to have performed this operation.
Professor Lord is Head of the Gastroesophageal Cancer Program at the St. Vincent’s Centre for Applied Medical Research, Head of Surgery at Notre Dame School of Medicine, conjoint Asssociate Professor of Surgery at UNSW, and adjunct Professor of Surgery at Macquarie University Advanced School of Medicine. He is Chair of the Sydney Upper Gastrointestinal Surgery Society, a member of the Upper Gastrointestinal NSW Oncology Group, and a past Cancer Institute NSW Clinical Research Fellow. He is a member of the Cancer Council NSW (CCNSW) cancer research committee and the CCNSW Strategic Research Partnership grant review committee, has served on NHMRC review panels, and regularly reviews grants for other countries.
He is a member of the Cancer Council Australia Guidelines Committee for Barrett’s oesophagus and neoplasia and was a member of the Advisory Panel to the Medical Services Advisory Committee investigating radiofrequency ablation for Barrett’s oesophagus. He has received personal awards including from the STOP Cancer Foundation USA and the Society of American Gastrointestinal and Endoscopic Surgeons. He is Associate Editor for Biomed Central Gastroenterology and reviews for many journals.
Professor Lord has given more than 60 invited presentations, mostly outside Australia. Recent invitations include International Guest Scholar of the American College of Surgeons, Visiting Professor at the University of Rochester Medical and Dental School, keynote lecturer at the Royal Australasian College of Surgeons annual meeting, and guest lecturer at the Annual Congress of the Argentine Association of Surgery. He pioneered the use of wireless pH oesophageal monitoring in Australia and was the first to use endoscopic radiofrequency ablation therapy for Barrett’s oesophagus in this country. He is an author on 70 original research publications, 8 reviews, 2 editorials, 12 book chapters, and more than 50 other publications including abstracts.